Asset Manager

Updated:

KBI Biopharma

KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical &...

KBI Biopharma

KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, and more.

General information

Firm type

Asset Manager

Location

Region

North America

Country

United States

City

Durham

Corporate office

Durham, NC, United States

Additional offices

Research Triangle Park, NC · Boulder, CO · Louisville, CO · The Woodlands, TX · Geneva, Switzerland · Leuven, Belgium

Principals

JSR Life Sciences

Parent Company

Sector focus

Healthcare Services

Frequently asked questions

How does KBI Biopharma source proprietary deal flow?

As a CDMO, KBI does not pursue proprietary deal flow in the investment sense. Its customer base is built through direct commercial engagement with biopharmaceutical developers who need development and manufacturing services. The company competes for contracts in the outsourced biologics manufacturing market.

Does KBI Biopharma participate in fund commitments or only direct deals?

KBI Biopharma does not participate in fund commitments or investment deals. It is a CDMO that provides fee-for-service development and manufacturing services to drug developers. There is no public evidence of an affiliated investment arm or corporate venture capital unit.

Which investment stages does KBI Biopharma typically target?

KBI Biopharma does not target investment stages. Its service model spans the drug development lifecycle from cell line development through commercial manufacturing, but this refers to the manufacturing maturity of a client's molecule, not an investment stage. The company supports clients ranging from preclinical startups to commercial-stage biopharmaceutical companies.

How is KBI Biopharma related to JSR Life Sciences?

KBI Biopharma is a wholly owned subsidiary of JSR Life Sciences, a global life sciences company headquartered in Japan. JSR Life Sciences provides corporate-level strategic alignment, including sustainability initiatives, while KBI operates its CDMO business across the US and Europe.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Durham Asset Manager profiles